r d News

Petrochemical infrastructure development is driven by growth in newly industrialised nations turning to the production of polymer products, and those which have a high demand for fertilisers and fuel additives.

Recently published research shows a major shift in global pharmaceutical companies outsourcing core research and development (R&D) services such as drug development and clinical trials through strategic third-party collaborative partnerships.

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

Domestic pesticide market continues to be depressed. Overcapacity is still the main reason to drag domestic pesticide industry in downturn.

The reauthorization of the SBIR and STTR programs are a significant win for American small business and affirm the government's commitment to supporting growth through innovation.

Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum.

Former U.S. Congressman Rick Lazio from New York joins tax specialty firm, alliantgroup, as Director

Professor Fuliang Chen from Plant Protection Institute of CAAS will present a speech on EC formulations policy, taking place on March 9th, 2012, at Ramada Plaza Gateway Shanghai, China.

Over the next decade, global demand for oil & gas is set to rapidly increase as rising populations and economic growth help to drive the industry. This will create a need for additional oil & gas infrastructure to be constructed.

Multiplying engineers resources with minimal investment, Chroma ATE announced its new 3110 Hybrid Handler for the Semiconductor Industry offering a compact footprint, fully automated device handing, multi bin sorting and remote capabilities.

Oil demand remains high despite the uncertainty in the global economy of late. Discoveries of light easy-to-produce crude oil are decreasing, with less than 10 billion barrels a year added to reserves over the last ten years.

Budget 2012 announced that the Research and Development (“R&D”) Tax Credit scheme would be altered. Leyton provide key analysis on these changes.

Cambridge Healthtech Institute just adds an interactive panel discussion to take place at its Integrated R&D Informatics & Knowledge Management conference on Feb. 21-23, 2012, San Francisco, CA.

Two distinguished researchers from Hong Kong Applied Science and Technology Research Institute (ASTRI), Dr Wang Keh-chung and Dr Wu Enboa were conferred the title of Fellow by IEEE.

A new report by visiongain, a London-based business information company, predicts that world revenues for antibacterial drugs will reach $43.81bn in 2016.

A new report by visiongain predicts that revenues for disease-modifying treatments for multiple sclerosis (MS) will rise to $15.8bn annually in 2015. That analysis appears in Multiple Sclerosis Treatment: World Drug Market 2012-2022.

CCS technology consists of capturing carbon dioxide (CO2) directly from industrial or utility plants and storing it in secure reservoirs, typically depleted oil and gas fields and saline aquifers.

A new report by visiongain, a London-based business information provider, predicts that the global medical device contract manufacturing revenues will reach $95.7bn in 2021.

TCG Lifesciences Limited (TCGLS) has announced that it has entered into a strategic agreement with JSW Lifesciences (JSW), a full services EU based CRO, to strengthen its R&D offerings in the area of Central Nervous System (CNS).

The oil & gas virtual reality training and simulation market is being driven by a combination of increasing demand for oil & gas, the retirement of the baby boomer generation, improving technologies, and increasing safety concerns.

A combination of high oil prices, oversupply of natural gas, increasing global energy demands, and improving extraction technologies is creating a renewed interest in the gas to liquids market.

Paradigm Partners has Selected MFG.com as a Strategic Partner With The Goal of Further Educating the Manufacturing Industry about Lucrative Tax Incentives.

A free webinar on China’s mancozeb was successfully held by CCM at 16:30 (GMT+8, Beijing Time) October 27, 2011.

Drug repositioning offers the possibility of breathing new life into pharmaceutical R&D. By recycling drug data, repositioning promises to boost production, accelerate and derisk R&D, and enhance product life-cycle management.

Cost and productivity benefits ensure greater traction for CRO services

Visiongain's The Oilfield Chemicals Market 2011-2021 report details the prospects for this dynamic energy sector with detailed forecasts from 2011-2021.

Visiongain's latest report, The Unconventional Gas Market 2011-2021: Shale Gas, Tight Gas, CBM & Methane Hydrate predict significant growth across the 4 main types of unconventional gas: Shale Gas, Tight Gas, Coalbed Methane & Methane Hydrate.

CROs experience two-tiered growth with pharma and biotech companies looking to outsource

Codespring and other 15 Romanian companies will meet their counterparts from Denmark and Sweden, on the occason of a special trade mission. Locations: Aarhus, Copenhagen, Stockholm and Linkoping. Duration: 30.10.2011 - 05.11.2011.

The Advanced Oil & Gas Exploration Technologies Market 2011-2021 is Visiongain's latest energy report, analysing how this important market will develop over the next ten years.

View IPR’s Most Recent Report Titles from the 2011 Catalog and Our Newly Launched Insight Update Series.

David Crabb, managing director of Cambridge Online met with Andrew Duff, MEP for East of England to find out how European Parliament can help regional businesses.

Visiongain predicts that world revenues for rheumatoid arthritis drugs will rise strongly between 2011 and 2021. This market will grow to reach $17.3bn in 2015. The rheumatoid arthritis drugs market generated $12.7bn in 2010.

A new report by visiongain predicts that the global companion diagnostics market will be worth $3.45bn by 2015. The market generated sales of $1.30bn in 2010, according to Companion Diagnostics: World Market Outlook 2011-2021, published in August.

A new report by visiongain, a London-based business information company, predicts that global pharmacovigilance spending will be worth $15.46bn by 2015. The market was worth just under $12bn in 2010.

World energy demand is growing at an incredible pace. As a result of rapid growth in demand for energy, conventional oil & gas fields are being depleted rapidly.

The Arctic Oil & Gas Exploration & Production (E&P) Market 2011-2021 report will be a valuable source of information to those already involved in the Arctic oil and gas E&P market and to those wishing to enter this pivotal market in the future.

Atlas R+D software allows a company to track and keep accurate records of all projects and hours related to research and development projects. In just minutes a day, all hours eligible for credit can be tracked for end of year tax filings.

Visiongain's The Oil Shale Market 2011-2021 report details the prospects for this dynamic energy sector with detailed forecasts. The report will be valuable to those already involved in the oil shale market or to those wishing to enter.

Ever-increasing demand for personalised medicine has enhanced the global requirement for biobanks to provide human tissue, body fluids and their derivatives.

The Florida TaxWatch research report supports Northeast Florida's Manufacturers' position on tax policy and incentive strategy for Florida.

A new report by visiongain, a London-based business information provider, predicts that the global drug discovery outsourcing market will be worth $16.21bn by 2015. The market generated $8.30bn in 2010.

CCM’s July issue of Seed China News indicates that China advocates strengthening supervision over foreign seed enterprises in domestic market.

R&D park’s first international tenant is lured by Miami’s proximity to Europe and Latin America, project’s advanced technology offerings.

3 hour course to be held in Philadelphia on October 3, 2011, by John Arrowsmith, Ph.D., Science Director, Europe, Thomson Life Sciences Consulting & Richard K. Harrison, Ph.D., Scientific Director, North America, Thomson Life Sciences Consulting

SMi Group is proud to announce its 10th annual Clinical Trials in CNS conference, which will be held in London on 23rd & 24th November 2011.

SMi Group is proud to announce its 8th annual Point of Care Diagnostics: Market Adoption and Technology Trends conference, which will be held in London on 19th and 20th October 2011.

SMi Group proudly announces its Managing Partnerships with CROs conference. Held on 3rd and 4th October 2011, the event addresses key issues such as new approaches to R&D methods & outsourcing activities & identifying risks in partnership formation.

SMi Group is proud to announce its 3rd annual Biomarkers in Clinical Trials conference, which will be held in London on 19th and 20th September 2011.

A policy specialist and a healthcare economist both say that the oft-quoted cost of $1.32 billion to bring a new drug to market does not hold up to close scrutiny